Despite the ongoing challenges presented by the COVID-19 pandemic, the UW Health Low Vision Clinic – led by Sanbrita Mondal, OD, clinical adjunct assistant professor – has announced that it will offer expanded services and …
Amy Pikalek
MAC TEL
Extension Study of NT-501 Ciliary Neurotrophic Factor (CNTF) Implant for Macular Telangiectasia (Mac Tel)
BIM2
To identify whether genetic variation or polymorphism in genes that impact angiogenesis can be identified as biomarkers for responsiveness to anti-VEGF therapy in patients with neovascular age-related macular degeneration.
GENETIC EYE DISORDERS
To identify the gene or genes responsible for developmental causes of blindness in the world, and to establish a Pediatric Ophthalmic Genetics and Research Program at the University of Wisconsin–Madison.
XOLARIS
To gain a better understanding of disease progression over time in male subjects with X-linked retinitis pigmentosa (XLRP).
CHM SURVEY TRIAL
Choroideremia (CHM) Health Outcomes
CATALINA
A Phase II Multicenter, Randomized, Double-Masked, Sham-Controlled Study of the Safety and Efficacy of Intravitreal Injections of NGM621 in Subjects with Geographic Atrophy (GA) Secondary to Age-Related Macular Degeneration (AMD) (CATALINA)
Meet Alicia Wolf, Social Worker with UW Health Patient Resources
Patient Services in Action: Alicia Wolf As the social worker for ophthalmology services, Alicia Wolf has been assisting our providers in connecting their patients to resources to cope with low vision, as …
Pro-EYS
Rate of Progression in EYS Related Retinal Degeneration (Pro-EYS).